In addition, miR-200c increases up to 6 months of APP/PS1 mice, but miR-200c expression decreases at 9 months of APP/PS1 mice, where both Aβ, phosphorylated tau, and cognitive impairment are observed 32. The gene discussed is MAPT; the disease is Cognitive impairment.